Engaging Global Payers for Better Trial Design

October 18, 2019Case Study

A clinical team wanted to design a Phase III trial for a new therapy used to treat a rare disease. To gauge the economic viability of the new treatment, the team needed to understand how global payer organizations would weigh the benefits of the new therapy, and where the treatment might be placed in formularies. The team used Within3 to conduct a three-week, multi-part online advisory board meeting to efficiently gather input from payers around the world.